Wednesday, June 17, 2026

HomeBreaking NewsGSK says tests hint COVID drug fights Omicron

GSK says tests hint COVID drug fights Omicron

- Advertisement -


Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant, the British drugmaker said on Thursday. Conway G. Gittens reports.



Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed